Seelos Therapeutics, Inc. (SEEL)

NASDAQ: SEEL · IEX Real-Time Price · USD

0.546

+0.022 (4.28%)

At close: Jul 19, 2024, 4:00 PM

0.540

-0.006 (-1.08%)

Pre-market: Jul 22, 2024, 7:21 AM EDT

Seelos Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Revenue	1.97	2.2	0	0	0	0.38	Upgrade
Revenue Growth (YoY)	144.31%	-	-	-	-	-	Upgrade
Gross Profit	1.97	2.2	0	0	0	0.38	Upgrade
Selling, General & Admin	11.62	12.59	12.3	15.02	7.78	7.56	Upgrade
Research & Development	27.97	30.12	58.62	46.65	10.98	22.56	Upgrade
Operating Expenses	39.6	42.7	70.92	61.67	18.76	30.12	Upgrade
Operating Income	-37.62	-40.5	-70.92	-61.67	-18.76	-29.75	Upgrade
Interest Expense / Income	0.09	0.08	0.01	1.6	0.16	0.03	Upgrade
Other Expense / Income	-10.6	-2.69	2.6	2.78	0.18	21.48	Upgrade
Pretax Income	-27.12	-37.88	-73.53	-66.05	-19.1	-51.26	Upgrade
Net Income	-27.12	-37.88	-73.53	-66.05	-19.1	-51.26	Upgrade
Shares Outstanding (Basic)	2	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	0	0	0	0	Upgrade
Shares Change	246.73%	38.20%	17.03%	103.03%	120.43%	559.03%	Upgrade
EPS (Basic)	-34.64	-61.84	-165.92	-175.20	-103.20	-604.80	Upgrade
EPS (Diluted)	-82.64	-61.84	-165.92	-175.20	-103.20	-604.80	Upgrade
Free Cash Flow	-18.21	-23.91	-61.6	-49	-20.91	-19.31	Upgrade
Free Cash Flow Per Share	-11.20	-39.04	-139.00	-129.37	-112.12	-228.14	Upgrade
Gross Margin	100.00%	100.00%	-	-	-	100.00%	Upgrade
Operating Margin	-1905.88%	-1838.36%	-	-	-	-7932.53%	Upgrade
Profit Margin	-1373.61%	-1719.56%	-	-	-	-13668.00%	Upgrade
Free Cash Flow Margin	-922.29%	-1085.43%	-	-	-	-5148.00%	Upgrade
EBITDA	-26.97	-37.75	-73.47	-64.45	-18.94	-51.23	Upgrade
EBITDA Margin	-1366.06%	-1713.57%	-	-	-	-13660.27%	Upgrade
Depreciation & Amortization	0.06	0.06	0.05	0	0	0	Upgrade
EBIT	-27.02	-37.81	-73.52	-64.45	-18.94	-51.23	Upgrade
EBIT Margin	-1369.00%	-1716.16%	-	-	-	-13660.27%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).